advertisement

Genetics

16 November 2011

Embryonic stem cell trial halted

The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs, and the company will focus instead on new cancer treatments, Geron said.

The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs, and the company will focus instead on new cancer treatments, Geron said.

The study was meant to include up to 10 people in the first-ever trial of embryonic stem cell therapy on humans.

No harmful effects 

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.